Biomea Fusion, Inc. Profile Avatar - Palmy Investing

Biomea Fusion, Inc.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioava…

Biotechnology
US, Redwood City [HQ]

Resulting Ratios

5 Records · Starting from 2019
Loading...
End of BMEA's Analysis
CIK: 1840439 CUSIP: 09077A106 ISIN: US09077A1060 LEI: - UEI: -
Secondary Listings
BMEA has no secondary listings inside our databases.